Approval Of New AstraZeneca COVID Vaccine Gives Stocks A Shot In The Arm.

FILE - This Saturday, July 18, 2020 file photo shows a general view of AstraZeneca offices and the corporate logo in Cambridge, England. Oxford University says on Saturday, Sept. 12 trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K. The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.” (AP Photo/Alastair Grant, file)

Another shot was fired in the global pandemic fight and investors are considering the impact. On Wednesday, Britain became the first country to approve the COVID-19 vaccine from Oxford University and AstraZeneca, whose stock was unsteady throughout the morning due largely to lingering uncertainty regarding its overall effectiveness.

AstraZeneca (AZN) joined the FTSE 100’s leaders as shares rose in early European trading and were up about 3.3% at the start of trade, but faded, off 46 points (0.63%) by mid-morning in New York.

This vaccine is the second to be approved in the U.K., where more than 600,000 already have been vaccinated with the first dose of the two-dose Pfizer-BioNTech shot.

Britain’s approval is “certainly good news because there is no doubt that the current coronavirus vaccine demand is nowhere close enough to supply,” Naeem Aslam, chief market analyst at AvaTrade, said in a Business Insider story.

In terms of expanding the approval, the European Union regulator, according to Reuters, says the data on the AstraZeneca shot is incomplete and is unlikely to be approved in the next couple of weeks. Britain’s coronavirus vaccine chair, Wei Shen Lim, said one dose was around 70% effective from 21 days until a second dose was given at 12 weeks.

Munir Pirmohamed, a British government COVID-19 expert involved in Wednesday’s approval, said two full doses, three months apart resulted in effectiveness of “up to 80% … which is the reason for our recommendation.”

AstraZeneca’s vaccine needs only standard refrigeration; other COVID shots need cold storage.

Market strategists have said the ease with which the AstraZeneca vaccine is distributed and stored should help slow or eliminate further U.K. restrictions. Several parts of England went into the highest tier of lockdowns on Dec. 20, with citizens advised to stay home.

Join the conversation!

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please hover over that comment, click the ∨ icon, and mark it as spam. Thank you for partnering with us to maintain fruitful conversation.